Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Pancreatic surgery.

W Uhl1, B Gloor, M W Büchler

  • 1Department of Visceral and Transplantation Surgery, University Hospital of Bern, Bern, Switzerland.

Current Opinion in Gastroenterology
|October 7, 2006
PubMed
Summary
This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Retraction Note: Expression of E-cadherin repressors SNAIL, ZEB1 and ZEB2 by tumour and stromal cells influences tumour-budding phenotype and suggests heterogeneity of stromal cells in pancreatic cancer.

British journal of cancer·2025
Same author

Expression of E-cadherin repressors SNAIL, ZEB1 and ZEB2 by tumour and stromal cells influences tumour-budding phenotype and suggests heterogeneity of stromal cells in pancreatic cancer.

British journal of cancer·2015
Same author

Trends and outcomes in the use of surgery and radiation for the treatment of locally advanced esophageal cancer: a propensity score adjusted analysis of the surveillance, epidemiology, and end results registry from 1998 to 2008.

Diseases of the esophagus : official journal of the International Society for Diseases of the Esophagus·2013
Same author

Tumour budding is a strong and independent prognostic factor in pancreatic cancer. Reply to comment.

European journal of cancer (Oxford, England : 1990)·2013
Same author

Tumour budding is a strong and independent prognostic factor in pancreatic cancer.

European journal of cancer (Oxford, England : 1990)·2012
Same author

Neoadjuvant chemoradiotherapy with or without panitumumab in patients with wild-type KRAS, locally advanced rectal cancer (LARC): a randomized, multicenter, phase II trial SAKK 41/07.

Annals of oncology : official journal of the European Society for Medical Oncology·2012

Pancreatitis and pancreatic cancer incidence is rising globally due to better diagnostics and lifestyle changes. Surgical interventions focus on organ preservation for inflammation and radical approaches for cancer.

Area of Science:

  • Gastroenterology and Surgical Oncology

Background:

  • Global incidence of acute and chronic pancreatitis and pancreatic cancer is increasing.
  • Improved diagnostic imaging (CT, MRI, SPECT, ERCP) and lifestyle factors contribute to rising rates.

Purpose of the Study:

  • To review recent surgical treatment options for acute and chronic pancreatitis.
  • To summarize surgical and multimodal therapeutic strategies for pancreatic cancer.

Main Methods:

  • Literature review of recently published articles on surgical management of pancreatic diseases.
  • Focus on organ-preserving surgeries for pancreatitis and radical surgery for cancer.

Main Results:

  • Organ- and organ function-preserving surgical procedures are primary interventions for acute and chronic pancreatitis.

Related Experiment Videos

  • Extended radical surgery and multimodal therapies offer the most benefit for pancreatic cancer.

    • Conclusions:

    • Surgical approaches are critical in managing both inflammatory pancreatic conditions and pancreatic cancer.
    • The choice of surgical strategy depends on the specific diagnosis, aiming for organ preservation or radical resection.